|
 |
ORIGINAL ARTICLE |
|
Year : 2020 | Volume
: 23
| Issue : 9 | Page : 1215-1220 |
|
Anterior bladder wall thickness, post-void urine residue, and bladder emptying efficiency as indicators of bladder dysfunction in Nigerian men with benign prostatic hyperplasia
BU Eze1, TU Mbaeri2, JC Orakwe2
1 Department of Surgery, Enugu State University of Science and Technology Teaching Hospital, Parklane-Enugu, Enugu State, Nigeria 2 Department of Surgery, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Anambra State, Nigeria
Date of Submission | 17-Feb-2020 |
Date of Acceptance | 03-Jun-2020 |
Date of Web Publication | 10-Sep-2020 |
Correspondence Address: Dr. B U Eze Department of Surgery, Enugu State University of Science and Technology Teaching Hospital, Parklane-Enugu, Enugu State Nigeria
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/njcp.njcp_67_20
Abstract | | |
Background: Benign Prostatic Hypertrophy [BPH] is associated with voiding dysfunctions. Urodynamic study is the gold standard for diagnosis of voiding dysfunctions but is invasive. Bladder wall thickness (BWT), post-void urine residue (PVR), and bladder emptying efficiency (BEE) are noninvasive predictors of voiding dysfunction. Objective: To study the relationship among BWT, PVR, and BEE in BPH. Subjects and Methods: A hospital-based cross-sectional prospective study of new BPH patients at Nnamdi Azikiwe University Teaching Hospital, Nnewi. The participants had abdominal ultrasonography measurement of anterior BWT (at bladder volume ≥200 mls), prostate volume (PV), and PVR using Prosound SSD3500 (Aloka Co Ltd, Tokyo, Japan) with an abdominal probe frequency of 3.5 MHz. Then the BEE was calculated. The anterior BWT was divided into two groups: <5 mm and ≥5 mm. The data were analyzed using SPSS version 20. Pearson's correlation was used to assess correlation and the differences between the means of the two groups of BWT were compared by Mann–Whitney test. A P- Value <0.05 was considered significant. Results: Seventy seven men with a mean age of 66.66 ± 10.74 years were included in the study. Sixty one percent had symptoms lasting >12 months. The average anterior BWT, PBV, PVR, BEE, PV, and PSA were 4.55 ± 1.02 mm, 260.98 ± 57.44 mls, 58.36 ± 52.94 mls, 77.98 ± 17.37%, 66.31 ± 46.38 mls, and 8.04 ± 5.97 ng/ml, respectively. There was a significant positive correlation between BWT and duration of symptoms (P = 0.044) and a significant negative correlation between BWT and BEE (P = 0.005). An insignificant positive correlation was found between BWT and PVR (P = 0.255). Fifty four (70.1%) had BWT <5 mm and 29.9% had BWT ≥5 mm. The mean IPSS (P = 0.000), PV (P = 0.032) and PVR (P = 0.020) were significantly higher in the ≥5 mm group. The ≥5 mm group also had a significantly lower BEE (P = 0.002). Conclusion: Voiding dysfunction was more severe in patients with BWT of 5 mm or more. There was a positive, but insignificant, correlation between anterior BWT and PVR and a significant negative correlation between BWT and BEE.
Keywords: Bladder emptying efficiency, bladder wall thickness, BPH, post-void urine residue, voiding dysfunction
How to cite this article: Eze B U, Mbaeri T U, Orakwe J C. Anterior bladder wall thickness, post-void urine residue, and bladder emptying efficiency as indicators of bladder dysfunction in Nigerian men with benign prostatic hyperplasia. Niger J Clin Pract 2020;23:1215-20 |
How to cite this URL: Eze B U, Mbaeri T U, Orakwe J C. Anterior bladder wall thickness, post-void urine residue, and bladder emptying efficiency as indicators of bladder dysfunction in Nigerian men with benign prostatic hyperplasia. Niger J Clin Pract [serial online] 2020 [cited 2021 Jan 22];23:1215-20. Available from: https://www.njcponline.com/text.asp?2020/23/9/1215/294688 |
Introduction | |  |
Benign prostatic hyperplasia (BPH) is a common cause of urinary problems in aging men.[1] BPH leads to constriction of the urethral lumen and gives rise to lower urinary tract symptoms (LUTS).[2] BPH causes bladder outlet obstruction (BOO) which is characterized by increased detrusor pressure, increased urethral resistance, and consequent reduced urine flow rate.[3] One of the primary characteristics of BOO due to BPH is an increase in bladder mass commonly referred to as bladder hypertrophy.[4]
In men with LUTS, without prior treatment and/or neurological disorders, ultrasound-assessed Bladder Wall Thickness (BWT) has a high predictive value for BOO and can replace pressure-flow studies for the diagnosis of BOO.[5] BWT can be measured on the anterior wall, lateral walls, trigone, or dome. The BWT measurements showed minimal differences between the sections of the bladder wall where measurements were performed.[6] Though there have been conflicting reports about the usefulness of BWT as a diagnostic tool in different ethnic groups,[7],[8] ultrasound measurements of BWT have been proposed as a useful diagnostic parameter in patients with BOO and other voiding dysfunctions.[9] BWT decreases rapidly during the first 200 millilitres of bladder filling and, thereafter, remains almost stable until maximal bladder capacity.[10],[11]
The International Continence Society (ICS) Committee on Standardization of Terminology defines post-void urine residue (PVR) as the volume of urine remaining in the bladder (immediately) following the completion of voiding.[12] The measurement of post-void urine residue plays a prominent role in evaluation of men with BOO due to BPH.[13] PVR is usually measured with transabdominal ultrasound instead of urethral catheterization because transabdominal ultrasound is reliable, inexpensive, and noninvasive in nature.[14],[15] Transabdominal ultrasonography has been reported to have high sensitivity and specificity for the estimation of PVR.[15] Catheterization carries the risk of infection and trauma to the urethra[16] and may, sometimes, be difficult to perform in patients with prostatic hypertrophy.[17] Though traditionally PVR has been used as one of the key parameters to assess bladder emptying, it has been established that no absolute value of PVR is an accurate and consistently reliable measurement of adequate bladder emptying.[18] On the other hand, it has been found that bladder emptying efficiency (BEE) is a clinically meaningful method of assessing bladder emptying function.[18],[19] BEE is a product of bladder contractility against urethral resistance and is measured according to the degree of bladder emptying.[20] BEE is defined as a percentage of volume voided compared to the pre-void bladder volume.[18],[20]
To diagnose voiding dysfunction, urodynamic studies are considered as the gold standard tests. Various investigators have attempted to evaluate various noninvasive tests to predict voiding dysfunctions; for example, international prostate symptom score (IPSS), PVR, BWT, and ultrasound estimated bladder weight.[21],[22] It has been shown that a large part of BPH symptoms may be explained by bladder dysfunction, which tends to be often not considered in discussions about BPH.[23] Early identification of bladder dysfunction by measuring BWT and PVR has been shown to have the advantage of adopting therapeutic measures sufficient to prevent progression of bladder damage.[24]
To our knowledge, no local study has been carried out to assess the correlation between anterior BWT and PVR. Voiding dysfunction is not routinely evaluated in patients with BPH at the study centre. Hence, there is a need for this study. This study was done to determine the relationship among BWT, PVR, and BEE in adult Nigerian male patients with BPH.
Subjects and Methods | |  |
This prospective cross-sectional study was conducted over a period of 15 months (October, 2014–December, 2015) among new BPH patients who presented to Nnamdi Azikiwe University Teaching Hospital, Nnewi. Ethical approval was obtained from the institutional ethical committee and written informed consents were obtained from the patients. The population comprised all new patients >40 years seen in the urology clinic with symptomatic BPH. Those patients with LUTS due to nonprostatic disorders, carcinoma of the prostate, previous pelvic or urethral surgeries, bladder calculi or carcinoma, neurologic deficit (s), on 5α reductase inhibitors, α-1 blockers, or anticholinergic medications and who were unable to hold enough urine to enable ultrasound measurement of parameters were excluded.
Patient evaluation included a detailed history with IPSS. A complete physical examination was done, which included digital rectal examination and neurological examination to exclude neurological deficit (s) and neurologically related bladder dysfunction. Urinalysis plus urine microscopy and culture were done to screen for diabetes mellitus and urinary tract infection. In addition, serum PSA was obtained and prostate biopsy was done for those with PSA >4 ng/ml to exclude carcinoma of the prostate.
Each subject was interviewed using a standard proforma which contained the patient's biodata, duration of symptoms, IPSS, associated symptoms, comorbidities, and ultrasound assessment of anterior BWT and PVR. To ensure quality control, only the lead researcher interviewed the patients and this was done in an enclosure to ensure confidentiality and free flow of information. BWT and PVR were assessed using transabdominal ultrasonography. The ultrasound machine used was a Prosound model SSD 3500 with an abdominal probe frequency of 3.5 MHz (Aloka co Ltd, Tokyo, Japan). Furthermore, to ensure quality control, abdominal ultrasound assessments were done by a single consultant radiologist.
The BWT was measured on the anterior bladder wall. With the assistance of magnification, the adventitia, detrusor and mucosa were identified [Figure 1]. Two ultrasonographic measurements of the anterior bladder wall in longitudinal scan and transverse scan were obtained at a bladder filling of ≥200 mls. The average was taken as the BWT value in millimetres. The average bladder wall thickness was divided into two groups (<5 mm and ≥ 5 mm) as was done by Manieri et al.[4]
Transabdominal ultrasound imaging was used to obtain both the sagittal and transverse (maintaining the same contact point and rotating the transducer through 90°) images of the largest cross sections of bladder visualized [Figure 2] both before and after voiding. The images were measured in three orthogonal directions: from the top to bottom of the bladder (y) and at 90° to this (z) in the sagittal plane and from left to right in the transverse plane (x) as was described by Dudley et al.[25] and Amole et al.[26]. The volume of urine in the bladder was calculated with the formula-
Urine Volume = 0.72 × Length (x) × Width (y) × Height (z)[27]
The bladder was allowed to fill with at least 200 ml of urine by asking the patient to void and then ingest at least 2 litres of water. The abdominal ultrasonography for measurement of anterior BWT was performed as from two hours later to allow adequate filling of the bladder (≥200 mls). The PVR was calculated (as the transabdominal ultrasound post-voiding volume) as soon as the patient got back from the washroom. The bladder emptying efficiency was calculated as follows-

Data collected was analyzed with Statistical Package for Social Sciences version 20 (IBM; SPSS, Chicago, IL, USA). The results obtained were expressed using tables and figures were applicable. The data was subjected to descriptive statistics and mean differences between the two groups of BWT were compared by Mann–Whitney test. Pearson's correlation was used to assess correlation where necessary. P value < 0.05 was considered significant.
Results | |  |
A total of 77 men who met the stringent inclusion criteria, and signed the consent form were recruited into the study. The age range of the subjects was 43–90 years, with a mean age of 66.66 ± 10.74 years. The majority of the participants (61.0%) had symptoms lasting more than 12 months as shown in [Figure 3]. | Figure 3: Percentage of participants with duration of BPH symptoms in months
Click here to view |
The average anterior BWT, pre-void bladder volume, PVR, BEE, prostate volume, and PSA were 4.55 ± 1.02 millimetres, 260.98 ± 57.44 millilitres, 58.36 ± 52.94 millilitres, 77.98 ± 17.37 percent, 66.31 ± 46.38 millilitres, and 8.04 ± 5.97 nanogram/millilitre, respectively.
The Pearson coefficient for the correlation between anterior BWT and duration of symptoms was 0.196 (P = 0.044). The Pearson coefficient for correlation between anterior BWT and PVR was 0.076 with a P value of 0.255. Furthermore, the Pearson coefficient for the correlation between anterior BWT and bladder emptying efficiency was -0.293 and the P value was 0.005. The scatter plots of relationships between anterior BWT and PVR and anterior BWT and BEE are shown in [Figure 4] and [Figure 5], respectively. | Figure 4: Scatter plot of relationship between anterior bladder wall thickness (mm) and post-void urine volume (mls)
Click here to view |
 | Figure 5: Scatter plot of relationship between anterior bladder wall thickness (mm) and bladder emptying efficiency (percent)
Click here to view |
Out of the 77 participants, 54 (70.1%) had anterior BWT < 5 mm while 23 (29.9%) had anterior BWT of 5 mm or more. The differences between those with anterior BWT <5 mm and those with anterior BWT ≥5 mm were as shown in [Table 1]. | Table 1: Differences between participants with anterior bladder wall thickness of<5 millimetres (mm) and those with anterior bladder thickness of ≥5 millimetres (mm)
Click here to view |
Discussion | |  |
The mean age of 66.66 years found in this study supports the fact that BPH is a disease of aging men and is more common in men over 50 years.[28] The mean age of 66.66 years was similar to the mean ages of 65.4 years (Aganovic et al.[29]) and 63.5 years (Güzel et al.[30]) in other parts of the world. It is also like a mean age of 61.78 years found in Africa by Elsaied and colleagues.[31]
The greater percentage of the participants (61.0%) presented more than twelve months from the onset of symptoms of BPH. Furthermore, long duration between the onset of symptoms and presentation might account for 94.8% of the participants presenting with moderate or severe grade symptoms, as assessed by IPSS, as symptoms of BPH are progressive.
The mean anterior BWT of 4.55 mm found in this study is similar to a mean BWT of 4.48 mm found in a group of patients with BPH by Ho et al.[32] It is more than the average anterior BWT of 2.2 mm reported by Jang and colleagues in a sample of healthy adults without BOO.[33] This supports the fact that infravesical obstruction by BPH can induce bladder hypertrophy.[2],[4],[33] The mean BWT in this study is smaller than the mean of 5.19 mm found by Yilmaz and others.[34] This may be due to the fact that Yilmaz and colleagues measured BWT at a lower bladder filling (150 mls), although they used the same abdominal probe frequency of 3.5 MHz as used in this study. Also, Karakose and co-workers,[28] at similar bladder filling as in this study, found a higher BWT of 5.25 mm using a higher abdominal ultrasound probe frequency of 7.5 MHz.
The mean PVR of 58.36 mls is in consonance to a mean PVR of 50.25 mls reported by Aganovic et al.[29] This value is smaller than the mean PVR of 89.97 mls and 83.27 mls found by Güzel et al.[30] and Elsaied et al.,[31] respectively. This might be due to a higher abdominal ultrasound probe frequency of 7.5 MHz used by Güzel and co-workers. It can also be due to the high inter-individual and test-retest variability of PVR as reported by Gratzke et al.[35]
This study found a positive correlation between BWT and duration of symptoms. This correlation is statistically significant (P = 0.034). This is in consonance with the works of Güzel et al.[30] and Yilmaz et al.[34] which also reported significant positive correlation between BWT and duration of obstruction. The longer the duration of symptoms, the more the bladder wall hypertrophy as the bladder tries to overcome the infravesical obstruction.
The weak positive, but not significant (P = 0.255), correlation between BWT and PVR is similar to that of Yilmaz and co-workers[34] who also reported no significant correlation between BWT and PVR. Other workers have reported significant positive correlation between BWT and PVR.[30],[36],[37] The reason why the positive correlation between BWT and PVR found in this study is not statistically significant might be because studies that found significant positive correlation used either a 6.5 MHz rectal ultrasound probe (Park et al.[36]) or a high frequency (7.5 MHz) abdominal ultrasound probe (Cakiroglu et al.[37] and Güzel et al.[30]). The use of a higher frequency ultrasound probe might lead to better resolution and more accurate measurement of anterior BWT.[38]
Comparing the differences in parameters between the two groups of BWT, significant differences were found among the prostate volume (P = 0.032), IPSS (P = 0.000) and PVR (P = 0.02) of participants with BWT <5 mm and those with BWT ≥5 mm. Participants with BWT ≥5 mm had larger mean prostate volume, IPSS score, and PVR. Yilmaz et al.,[34] found no significant difference in IPSS, prostate volume, and PVR between a similar groups of participants. This difference might arise from the fact that the bladder in their study was filled with 150 mls of saline while the bladder was allowed to be filled passively with at least 200 mls of urine in this study. Measuring bladder wall thickness at bladder volume less than 200 mls leads to a higher value.[10]
The assessment of bladder emptying is an important component in evaluating the emptying phase function of the lower urinary tract.[18] Efficient voiding requires bladder outlet relaxation followed by a detrusor contraction that is enough to overcome the remaining resistance of the outlet. Many men develop increased outlet resistance with aging as a result of prostatic hypertrophy.[4] If more than 90% bladder emptying efficiency is not achieved, it is considered as indication of voiding dysfunction.[18],[19] The mean bladder emptying efficiency of 77.98 ± 17.37 percent (range: 36.96-98.09%) found in this study is an indication of bladder dysfunction in the studied participants with BPH. The finding that the mean bladder emptying efficiency of those with BWT <5 mm (82.14%) is significantly more (P = 0.002) than that of those with BWT ≥5 mm (68.22%) shows that those with BWT ≥5 mm have significantly higher voiding dysfunction.
Conclusion | |  |
The findings of this study show a positive, but statistically insignificant, correlation between BWT and PVR. It also found a significant negative correlation between BWT and bladder emptying efficiency. Voiding dysfunction, as assessed by bladder emptying efficiency, was present in patients with BPH and the dysfunction was more in patients with BWT of 5 mm or more. The implication is that patients with BWT of 5 mm or more may not likely have their symptoms completely resolved by prostatectomy because of the associated bladder dysfunction.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patients have given their consent for their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References | |  |
1. | Zhang SJ, Qian HN, Zhao Y, Sun K, Wang HQ, Liang GQ, et al. Relationship between age and prostate size. Asian J Androl 2013;15:116-20. |
2. | Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: Epidemiology, economics and evaluation. Can J Urol 2015;22:1-6. |
3. | Wei JT, Calhoun E, Jacobsen SJ. Urologic Diseases in America Project: Benign prostatic hyperplasia.J Urol 2005;173:1256-61. |
4. | Manieri C, Carter SS, Romano G, Trucchi A, Valenti M, Tubaro A. The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness. J Urol 1998;159:761-5. |
5. | Oelke M, Hofner K, Jonas U, Jean J, Ubbink DT, Wijkstra H. Diagnostic accuracy of non-invasive test to evaluate bladder outlet obstruction in men: Detrusor wall thickness, post void residual urine and prostate volume. Eur Urol 2007;52:827-34. |
6. | Schoor RA, Canning DA, Bella RD, Broderick GA, Snyder HM III, Duckett JW, et al. Ultrasound diagnosis of bladder outlet obstruction in rabbits. Neurourol Urodyn 1994;13:559-69. |
7. | Andersson KE. Storage and voiding symptoms: Pathophysiologic aspects. Urology 2003;62(Suppl 5B):3-10. |
8. | Galosi AB, Mazzaferro D, Lacetera V, Muzzonigro G, Martino P, Tucci G. Modifications of the bladder wall (organ damage) in patients with bladder outlet obstruction: Ultrasound parameters. Arch Ital Urol Androl 2012;84:263-7. |
9. | Andersson KE. Neurophysiology & pharmacology of the lower urinary tract. In: Tanagho EA, McAninch JW, editors. Smith's General Urology. 17 th ed.. New York: McGraw-Hill; 2008. p. 426-37. |
10. | Oelke M, Hofner K, Jonas U, Ubbink D, de la Rosette J, Wijkstra H. Ultrasound measurement of detrusor wall thickness in healthy adults. Neurourol Urodyn 2006;25:308-17. |
11. | Chan L, The S, Titus J, Tse V. The value of bladder wall thickness measurement in the assessment of overactive bladder syndrome. Ultrasound Obstet Gynecol 2005;26:460-60. |
12. | Kessler TM, Gerber R, Burkharel FC, Studer UE, Danuser H. Ultrasound assessment of detrusor thickness in men- can it predict bladder outlet obstruction and replace pressure flow study. J Urol 2006;175:2170-3. |
13. | Bright E, Oelke M, Tubaro A, Abrams P. Ultrasound estimated bladder weight and measurement of wall thickness- useful noninvasive methods for assessing the lower urinary tract&? J Urol 2010;184:1847-54. |
14. | Kaplan SA, Wein AJ, Staskin DR, Roehrborn CG, Steers WD. Urinary retention and post-void residual urine in men: Separating truth from tradition. Br J Urol 2008;180:47-54. |
15. | Yang SS, Chiang I, Chang S. Interpretation of uroflowmetry and post-void residual urine in children: Fundamental approach to pediatric non-neurogenic voiding dysfunctions. Incont Pelvic Floor Dysfunct 2012;6:9-12. |
16. | Simfroosh N, Dadkhah F, Hosseini SY, Asgari MA, Nasseri A, Safarinejad MR. Accuracy of residual urine measurement in men: Comparison between real-time ultrasonography and catheterization.J Urol 1997;158:59-61. |
17. | Nishizawa O, Matsuzaki A, Kohama T, Suzuki T, Noto H. Noninvasive screening procedure for evaluation of bladder-emptying function. Tohoku J Exp Med 1985;147:421-5. |
18. | Cholhan H, Julia J, Hutchings T, Kocur B. Voiding efficiency: A new method of assessing bladder emptying function in women. Int Urogynecol J 2010;21:S59-60. |
19. | Leung VY, Chiu-Wing CW, Yeung CK, Metreweli C. The ureteric jet Doppler waveform and bladder wall thickness in children with nocturnal enuresis. Pediatr Res 2006;60:582-6. |
20. | Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: Three simple indices to define bladder voiding function. BJU Int 1999;84:14-5. |
21. | Chen CS. Differential diagnosis of benign prostate hyperplasia with lower urinary tract symptoms. Incont Pelvic Floor Dysfunct 2007;1(Suppl 2):9-13. |
22. | Comiter CV, Sullivan MP, Schacterle RS, Cohen LH, Yalla SV. Urodynamic risk factors for renal dysfunction in men with obstructive and non obstructive voiding dysfunction. J Urol 1987;158:181-5. |
23. | Miliceric S. Tamsulosin efficiency in treatment of benign prostatic hyperplasia evaluated by determining bladder weight. Med Arch 2012;66:391-5. |
24. | Eckhardt MD, Van Venrooij GE, Van Melick HH, Boon TA. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being. J Urol 2001;166:563-8. |
25. | Dudley NJ, Kirkland M, Lovett J, Watson AR. Clinical agreement between automated and calculated ultrasound measurements of bladder volume. Br J Radiol 2003;76:832-4. |
26. | Amole AO, Kuranga SA, Oyejola BA. Sonographic assessment of postvoid residual urine volumes in patients with benign prostatic hyperplasia. J Natl Med Assoc 2004;96:234-9. |
27. | Bih LI, Ho CC, Tasi SJ, Lai YC, Chow W. Bladder shape impact on the accuracy of ultrasonic estimation of bladder volume. Arch Phys Med Rehabil 1998;79:1553-6. |
28. | Karakose A, Aydogdu O, Atesci Y. The relationship between bladder wall thickness and lower urinary tract symptoms: Does bladder wall thickness change after alpha-blocker therapy with alfuzosin&? Can Urol Assoc J 2014;8:e26-9. |
29. | Aganovic D, Hasanbegovic M, Prcic A, Kulovac B, Hadziosmanovic O. Which is a better indicator of bladder outlet vobstruction in patients with benign prostatic enlargement- intravesical protrusion of prostate or bladder wall thickness&? Med Arch 2012;66:321-8. |
30. | Güzel O, Asla Y, Balci M, Tuncel A, Keten T, Erkan A, et al. Can bladder wall thickness measurement be used for detecting bladder outlet obstruction&? Urology 2015;86:439-44. |
31. | Elsaied W, Mosharafa A, Elfayoumy H, ElGhoniemy M, Ziada A, ElGhamrawy H, et al. Detrusor wall thickness compared to other non-invasive methods in diagnosing men with bladder outlet obstruction: A prospective controlled study. Afr J Urol 2013;19:160-4. |
32. | Ho CCK, Ngoo KS, Hamzaini AH, Rizal AM, Zulkifli MZ. Urinary bladder characteristics via ultrasound as predictors of acute urinary retention in men with benign prostatic hyperplasia. Clin Ter 2014;165:41-7. |
33. | Jang HA, Lee JG, Bae JH, OH, MM. Measurement of bladder wall thickness in the healthy Korean adults and its feasibility in diagnosing bladder outlet obstruction in the patient with lower urinary tract symptoms. Neurourol Urodyn2013;32:640-1. |
34. | Yilmaz A, Aslan Y, Uzun B, Tekdogan U, Tuncel A, Atan A. Relationship between bladder wall thickness and duration of symptoms, uroflowmetry parameters, and international prostate symptom score in patients with lower urinary tract symptoms. Turk J Urol2009;35:361-5. |
35. | Gratzke C, Bachmann A, Descazeaud A, Drake JM, Madersbacher S, Mamoulakis C, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2015;67:1099-109. |
36. | Park JS, Lee HW, Lee SW, Moon HS, Park HY, Kim YT. Bladder wall thickness is associated with responsiveness of storage symptoms to alpha-blockers in men with lower urinary tract symptoms. Korean J Urol 2012;53:487-91. |
37. | Cakiroglu B, Gozukucuk R, Sinanoglu O, Aksoy SH, Tas T, Eyyupoglu SE, et al. The correlation of symptoms severity and objective measures in patients with lower urinary tract symptoms. Clin Med Res 2013;2:135-9. |
38. | Tokgöz Ö, Tokgöz H, Û—nal I, Delibas U, Yildiz S, Voyvoda N, et al. Diagnostic values of detrusor wall thickness, postvoid residual urine, and prostate volume to evaluate lower urinary tract symptoms in men. Diagn Interv Radiol 2012;18:277-81. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]
[Table 1]
|